Mackenzie Financial Corp Spring Works Therapeutics, Inc. Transaction History
Mackenzie Financial Corp
- $71.6 Billion
- Q2 2025
A detailed history of Mackenzie Financial Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 4,408 shares of SWTX stock, worth $207,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,408Holding current value
$207,131% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
242Shares Held
70.4MCall Options Held
11.4MPut Options Held
1.27M-
Vanguard Group Inc Valley Forge, PA7.13MShares$335 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
Glazer Capital, LLC New York, NY4.11MShares$193 Million6.9% of portfolio
-
Fil LTD Hamilton, D03.01MShares$142 Million0.13% of portfolio
-
State Street Corp Boston, MA2.99MShares$141 Million0.01% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...